NDC 42794-014

Griseofulvin

Griseofulvin

Griseofulvin is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Sigmapharm Laboratories, Llc. The primary component is Griseofulvin.

Product ID42794-014_c7a8855f-39a8-6ee3-e053-2995a90a69df
NDC42794-014
Product TypeHuman Prescription Drug
Proprietary NameGriseofulvin
Generic NameGriseofulvin
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2012-11-15
Marketing CategoryANDA /
Application NumberANDA202545
Labeler NameSigmapharm Laboratories, LLC
Substance NameGRISEOFULVIN
Active Ingredient Strength250 mg/1
Pharm ClassesDecreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 42794-014-08

30 TABLET in 1 BOTTLE (42794-014-08)
Marketing Start Date2016-05-11
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Griseofulvin" or generic name "Griseofulvin"

NDCBrand NameGeneric Name
0472-0013GriseofulvinGriseofulvin
0713-0850GriseofulvinGriseofulvin
0781-5514GriseofulvinGriseofulvin
0781-5515GriseofulvinGriseofulvin
42794-012GriseofulvinGriseofulvin
42794-013GriseofulvinGriseofulvin
42794-014GriseofulvinGriseofulvin
62135-968GriseofulvinGriseofulvin (microsize)
64980-184GriseofulvinGriseofulvin
64980-185GriseofulvinGriseofulvin
64980-186GriseofulvinGriseofulvin
68682-519GriseofulvinGriseofulvin
68682-520GriseofulvinGriseofulvin
0884-0763Gris-PEGgriseofulvin
0884-0773Gris-PEGgriseofulvin
53808-0261Gris-PEGGRISEOFULVIN
62135-496Griseofulvin MICROSIZEgriseofulvin
62135-494Ultramicrosize GriseofulvinGriseofulvin
62135-495Ultramicrosize GriseofulvinGriseofulvin

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.